H.C. Wainwright affirmed its Buy rating on Omeros Corp. (Nasdaq: OMER) and established a price target of $34.00. Shares of the biopharmaceutical soared $1.34 to close at 13.49.
Omeros' Buy rating affirmed
April 04, 2018 at 20:24 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.